Clinical characteristics of Korean lung cancer patients with programmed death-ligand 1 expression

被引：0
|
作者：
Park, H-Y. [1 ]
机构：
[1] Chonnam Natl Univ, Hwasun Hosp, Pulm Internal Med, Hwasun, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 04期
关键词：
D O I：
10.1016/S1556-0864(18)30325-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
48P
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [41] Programmed Death-1 and Programmed Death-Ligand 1 Expression Patterns in Pediatric Lymphoma
    Tamura, Akihiro
    Yoshida, Makiko
    Yamamoto, Nobuyuki
    Nino, Nanako
    Nakatani, Naoko
    Ichikawa, Takayuki
    Nakamura, Sayaka
    Saito, Atsuro
    Kozaki, Aiko
    Kishimoto, Kenji
    Ishida, Toshiaki
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    BLOOD, 2018, 132
  • [42] CYTOLOGICAL TESTING OF NOVEL PROGRAMMED DEATH-LIGAND 1 IN LUNG CANCER PATIENTS ON BRONCHOSCOPIC NEEDLE ASPIRATION
    Safi, Javeryah
    Kim, Hyun
    Khemasuwan, Danai
    CHEST, 2019, 156 (04) : 1773A - 1773A
  • [43] Programmed Death-Ligand 1 and Programmed Death-Ligand 2 Expression Can Affect Prognosis in Extramammary Paget's Disease
    Kawaguchi, Aya
    Akiba, Jun
    Kondo, Reiichiro
    Sadashima, Eiji
    Ogasawara, Sachiko
    Naito, Yoshiki
    Kusano, Hironori
    Sanada, Sakiko
    Muto, Ikko
    Nakama, Takekuni
    Yano, Hirohisa
    ANTICANCER RESEARCH, 2021, 41 (01) : 219 - 226
  • [44] Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung
    Imanishi, Naoko
    Hirai, Ayako
    Yoneda, Kazue
    Shimajiri, Shohei
    Kuwata, Taiji
    Tashima, Yuko
    Takeuchi, Masahiro
    Iwai, Yoshiko
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) : 1563 - 1569
  • [45] Smoking signature is superior to programmed death-ligand 1 expression in predicting pathological response to neoadjuvant immunotherapy in lung cancer patients
    Yang, Haitang
    Ma, Wenyan
    Sun, Beibei
    Fan, Liwen
    Xu, Ke
    Hall, Sean R. R.
    Al-Hurani, Mohammad Faisal
    Schmid, Ralph A.
    Peng, Ren-Wang
    Hida, Toyoaki
    Wang, Zhexin
    Yao, Feng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (09) : 3807 - +
  • [46] Clinicopathological features of thymoma with the expression of programmed death-ligand 1
    Hakiri, S.
    Fukui, T.
    Mori, S.
    Kawaguchi, K.
    Nakamura, S.
    Ozeki, N.
    Kato, T.
    Goto, M.
    Yatabe, Y.
    Yokoi, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [47] Relationship between Clinical Factors and the Expression of Programmed Death Ligand 1 in Lung Cancer
    Kato, Y.
    Watanabe, K.
    Kashima, J.
    Hashimoto, K.
    Fukuda, A.
    Mitsuhashi, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2427 - S2427
  • [48] Programmed death-ligand 1 expression in carcinoma of unknown primary
    Kim, Hye Min
    Koo, Ja Seung
    BMC CANCER, 2024, 24 (01)
  • [49] Programmed death-ligand 1 testing of lung cancer cytology specimens obtained with bronchoscopy
    Stoy, Sean P.
    Rosen, Lauren
    Mueller, Jeffrey
    Murgu, Septimiu
    CANCER CYTOPATHOLOGY, 2018, 126 (02) : 122 - 128
  • [50] Genetic evidence for the causal association between programmed death-ligand 1 and lung cancer
    Yang, Zhao
    Yu, Rong
    Deng, Wei
    Wang, Weihu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (11) : 3279 - 3288
12345